PNC Financial Services Group
RIGL icon

PNC Financial Services Group’s Rigel Pharmaceuticals RIGL Stock Holding History

PNC Financial Services Group’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06K Sell
27
-5
-16% -$154 ﹤0.01% 4826
2026
Q1 		$865 Hold
32
– – ﹤0.01% 4789
2025
Q4 		$1.37K Buy
32
+17
+113% +$641 ﹤0.01% 4621
2025
Q3 		$425 Hold
15
– – ﹤0.01% 4835
2025
Q2 		$281 Buy
+15
New +$284 ﹤0.01% 4768
2024
Q3 		– Sell
-1,034
Closed -$8.5K – 4898
2024
Q2 		$8.5K Buy
1,034
+34
+3% +$356 ﹤0.01% 3830
2024
Q1 		$14.8K Sell
1,000
-100
-9% -$1.35K ﹤0.01% 3592
2023
Q4 		$15.9K Hold
1,100
– – ﹤0.01% 3558
2023
Q3 		$11.9K Buy
1,100
+100
+10% +$1.2K ﹤0.01% 3675
2023
Q2 		$12.9K Hold
1,000
– – ﹤0.01% 3757
2023
Q1 		$13.2K Hold
1,000
– – ﹤0.01% 3687
2022
Q4 		$15K Hold
1,000
– – ﹤0.01% 3610
2022
Q3 		$12K Sell
1,000
-65
-6% -$879 ﹤0.01% 3676
2022
Q2 		$11K Hold
1,065
– – ﹤0.01% 3778
2022
Q1 		$32K Hold
1,065
– – ﹤0.01% 3347
2021
Q4 		$29K Hold
1,065
– – ﹤0.01% 3386
2021
Q3 		$38K Buy
1,065
+65
+7% +$2.56K ﹤0.01% 3222
2021
Q2 		$43K Hold
1,000
– – ﹤0.01% 3150
2021
Q1 		$34K Hold
1,000
– – ﹤0.01% 3183
2020
Q4 		$35K Buy
+1,000
New +$28.9K ﹤0.01% 3102
2016
Q3 		– Sell
-75
Closed -$2K – 4225
2016
Q2 		$2K Sell
75
-2
-3% -$50 ﹤0.01% 4208
2016
Q1 		$2K Buy
77
+2
+3% +$49 ﹤0.01% 4208
2015
Q4 		$2K Sell
75
-600
-89% -$18.2K ﹤0.01% 4192
2015
Q3 		$16K Sell
675
-1,197
-64% -$35.7K ﹤0.01% 3476
2015
Q2 		$60K Buy
1,872
+72
+4% +$2.75K ﹤0.01% 2929
2015
Q1 		$64K Hold
1,800
– – ﹤0.01% 2916
2014
Q4 		$40K Hold
1,800
– – ﹤0.01% 2882
2014
Q3 		$34K Buy
+1,800
New +$50.8K ﹤0.01% 2857

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PNC Financial Services Group's RIGL Position: Q2 2026 in Review

PNC Financial Services Group reduced its Rigel Pharmaceuticals (RIGL) stake by 16% in Q2 2026, selling an estimated $154 and leaving 27 shares worth $1.06K. The position accounts for ﹤0.01% of the portfolio, ranked #4826.

PNC Financial Services Group first reported a position in RIGL in Q3 2014 and has held it in 28 quarters since. The position peaked at $64K in Q1 2015. 155 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • PNC Financial Services Group held 27 shares of Rigel Pharmaceuticals worth $1.06K as of Q2 2026.
  • PNC Financial Services Group sold 5 Rigel Pharmaceuticals shares in Q2 2026, an estimated $154.
  • Rigel Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4826 holding.
  • PNC Financial Services Group first reported a position in Rigel Pharmaceuticals in Q3 2014 and has held it in 28 quarters since.
  • PNC Financial Services Group's Rigel Pharmaceuticals position peaked at $64K in Q1 2015.
  • 155 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.